Plasma Metabolomic Profiling of Patients with Serial Coronary Atheroma Progression for Predicting Myocardial Infarction and Death

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Heart attacks are the leading cause of death, and half of all 1st heart attack victims have </= 1 known risk factors for coronary heart disease. There is an urgent need to better predict heart attack risk, and to develop new drugs to combat atherosclerosis. This study will involve a more advanced technique of identifying new molecules found in people who demonstrate progression of coronary atherosclerosis, heart attack and death, in the setting of a large-scale clinical trial testing a new agent that dramatically lowers cholesterol.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $373,114.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

angina | atherosclerosis | biomarkers | coronary artery disease | imaging | lipoproteins | metabolomics | myocardial infarction risk